Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

Roche is expanding its scope to a promising but competitive new obesity target, committing $1.65 billion up ... with “biased signaling” that de-emphasizes pathways that could diminish ...

Eating too fast could be making you gain weight without realizing it. Discover how slowing down can help regulate appetite and improve metabolism.

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...

As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

Before that, it dropped the development of another oral GLP-1 called lotiglipron, after finding a signal that it may cause liver toxicity in some patients. It had been planning to start a phase 3 ...

If you’ve been paying attention to the weight loss world, you’ve probably heard about GLP-1 receptor agonists like Ozempic, ...

Joslin Diabetes Center researchers are making discoveries that improve diabetes care and move us closer to a cure. Read ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...